Treatment of toxic epidermal necrolysis and concurrent COVID-19-associated hyperinflammatory syndrome with systemic corticosteroids and etanercept.
Treatment of toxic epidermal necrolysis and concurrent COVID-19-associated hyperinflammatory syndrome with systemic corticosteroids and etanercept.
复制标题
与全身性皮质类固醇和依那耐酸的有毒表皮坏死术和同时相关的高炎性综合征的同时治疗。
DOI：
10.1016/j.jdcr.2022.09.009
复制
发表时间：
2022-11
影响因子：
--
通讯作者：
Nelson, Caroline A
中科院分区：
文献类型：
--
作者：
Choi, Rachel;Garritano, James;Laird, Mary;Johnston, Margaret;Tkachenko, Elizabeth;Damsky, William;Little, Alicia J;McNiff, Jennifer;Girardi, Michael;Nelson, Caroline A
史蒂文斯约翰逊综合征（SJS）/中毒性表皮坏死松解症（TEN）是一种严重的皮肤不良反应。我们报告了一例TEN并发COVID-19相关高炎症综合征（cHIS）的病例，该病例通过全身性皮质类固醇和依那西普成功治疗。
Stevens Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) is a severe cutaneous adverse reaction. We report a case of TEN and concurrent COVID-19-associated hyperinflammatory syndrome (cHIS) successfully treated with systemic corticosteroids and etanercept.